- Home
- CLW vs ZVRA Comparison
CLW vs ZVRA Comparison
Compare CLW & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLW
- ZVRA
- Stock Information
- Founded
- CLW 2005
- ZVRA 2006
- Country
- CLW United States
- ZVRA United States
- Employees
- CLW N/A
- ZVRA N/A
- Industry
- CLW Paper
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- CLW Basic Materials
- ZVRA Health Care
- Exchange
- CLW Nasdaq
- ZVRA Nasdaq
- Market Cap
- CLW 438.0M
- ZVRA 433.5M
- IPO Year
- CLW N/A
- ZVRA 2015
- Fundamental
- Price
- CLW $24.97
- ZVRA $7.32
- Analyst Decision
- CLW Buy
- ZVRA Strong Buy
- Analyst Count
- CLW 1
- ZVRA 8
- Target Price
- CLW $37.00
- ZVRA $22.29
- AVG Volume (30 Days)
- CLW 238.3K
- ZVRA 504.8K
- Earning Date
- CLW 04-28-2025
- ZVRA 03-11-2025
- Dividend Yield
- CLW N/A
- ZVRA N/A
- EPS Growth
- CLW 85.61
- ZVRA N/A
- EPS
- CLW 11.70
- ZVRA N/A
- Revenue
- CLW $1,383,600,000.00
- ZVRA $23,612,000.00
- Revenue This Year
- CLW $14.27
- ZVRA $281.10
- Revenue Next Year
- CLW N/A
- ZVRA $97.98
- P/E Ratio
- CLW $2.14
- ZVRA N/A
- Revenue Growth
- CLW 21.80
- ZVRA N/A
- 52 Week Low
- CLW $22.58
- ZVRA $4.20
- 52 Week High
- CLW $57.13
- ZVRA $9.76
- Technical
- Relative Strength Index (RSI)
- CLW 46.52
- ZVRA 39.42
- Support Level
- CLW $24.60
- ZVRA $7.78
- Resistance Level
- CLW $26.21
- ZVRA $8.33
- Average True Range (ATR)
- CLW 0.89
- ZVRA 0.34
- MACD
- CLW 0.30
- ZVRA -0.06
- Stochastic Oscillator
- CLW 69.42
- ZVRA 4.11
About CLW Clearwater Paper Corporation
Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.